Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-04-2023 | Myasthenia Gravis | Case report

Erenumab

Ocular myasthenia gravis-like symptoms: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Marusic S, et al. Ocular myasthenia gravis-like symptoms associated with erenumab: Case report. International Journal of Clinical Pharmacology and Therapeutics 61 : 178-180, No. 4, Jan 2023. Available from: URL: http://doi.org/10.5414/CP204340 Marusic S, et al. Ocular myasthenia gravis-like symptoms associated with erenumab: Case report. International Journal of Clinical Pharmacology and Therapeutics 61 : 178-180, No. 4, Jan 2023. Available from: URL: http://​doi.​org/​10.​5414/​CP204340
Metadata
Title
Erenumab
Ocular myasthenia gravis-like symptoms: case report
Publication date
01-04-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38026-0

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Antineoplastics

Case report

Brolucizumab

Case report

Antineoplastics